消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

非酒精性脂肪性肝病中医诊疗专家共识意见（2017）

2017-10-03 中华中医药学会脾胃病分会 中医杂志.2017,58(19):1706-1710.

非酒精性脂肪性肝病中医诊疗

中华中医药学会脾胃病分会于2014 年8 月在合肥牵头成立了《非酒精性脂肪性肝病中医诊疗专家共识意见》起草小组。小组成员依据循证医学的原理，广泛搜集循证资料，并先后组织国内脾胃病专家就NAFLD 的证候分类、辨证治疗、诊治流程、疗效标准等一系列关键问题进行总结讨论，形成本共识意见初稿，之后按照国际通行的德尔菲法进行了3 轮投票。2015 年9 月在重庆进行了第一次投票，并根据专家意见对本共识意见进

中文标题：

非酒精性脂肪性肝病中医诊疗专家共识意见（2017）

发布机构：

中华中医药学会脾胃病分会

发布日期：

2017-10-03

简要介绍：

中华中医药学会脾胃病分会于2014 年8 月在合肥牵头成立了《非酒精性脂肪性肝病中医诊疗专家共识意见》起草小组。小组成员依据循证医学的原理，广泛搜集循证资料，并先后组织国内脾胃病专家就NAFLD 的证候分类、辨证治疗、诊治流程、疗效标准等一系列关键问题进行总结讨论，形成本共识意见初稿，之后按照国际通行的德尔菲法进行了3 轮投票。2015 年9 月在重庆进行了第一次投票，并根据专家意见对本共识意见进行了修改。2015 年12 月，在北京进行了第二次投票。2016年6 月，中华中医药学会脾胃病分会在厦门召开核心专家讨论会，来自全国各地20 余名脾胃病知名专家对本共识意见( 草案) 进行了第三次投票，并进行了讨论和修改。2016 年7 月，在哈尔滨第28 届全国脾胃病学术会议上专家再次进行了讨论、修改和审定，并于2016 年9 月在北京召开了本共识的最后专家定稿会议，完成了本共识意见的制定

 

拓展指南：与脂肪肝相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=非酒精性脂肪性肝病中医诊疗专家共识意见（2017）)] GetToolGuiderByIdResponse(projectId=1, id=cd2461c00150631f, title=非酒精性脂肪性肝病中医诊疗专家共识意见（2017）, enTitle=, guiderFrom=中医杂志.2017,58(19):1706-1710., authorId=null, author=, summary=中华中医药学会脾胃病分会于2014 年8 月在合肥牵头成立了《非酒精性脂肪性肝病中医诊疗专家共识意见》起草小组。小组成员依据循证医学的原理，广泛搜集循证资料，并先后组织国内脾胃病专家就NAFLD 的证候分类、辨证治疗、诊治流程、疗效标准等一系列关键问题进行总结讨论，形成本共识意见初稿，之后按照国际通行的德尔菲法进行了3 轮投票。2015 年9 月在重庆进行了第一次投票，并根据专家意见对本共识意见进, cover=, journalId=null, articlesId=null, associationId=645, associationName=中华中医药学会脾胃病分会, associationIntro=中华中医药学会脾胃病分会是由民政部备案并于中国科协登记注册的，隶属于中华中医药学会的二级学会。脾胃病分会现任主任委员是首都医科大学附属北京中医医院张声生教授，名誉主任委员李乾构、周学文、单兆伟教授；学会现有学术顾问26名、副主任委员5名、常委36名、委员95名，急症学组委员24名，人员涉及全国29个省市自治区，是全国从事中医、中西医结合消化病临床、科研与教学等工作的专家学者们学术交流的纽带与平台。, copyright=0, guiderPublishedTime=Tue Oct 03 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>中华中医药学会脾胃病分会于2014 年8 月在合肥牵头成立了《非酒精性脂肪性肝病中医诊疗专家共识意见》起草小组。小组成员依据循证医学的原理，广泛搜集循证资料，并先后组织国内脾胃病专家就NAFLD 的证候分类、辨证治疗、诊治流程、疗效标准等一系列关键问题进行总结讨论，形成本共识意见初稿，之后按照国际通行的德尔菲法进行了3 轮投票。2015 年9 月在重庆进行了第一次投票，并根据专家意见对本共识意见进行了修改。2015 年12 月，在北京进行了第二次投票。2016年6 月，中华中医药学会脾胃病分会在厦门召开核心专家讨论会，来自全国各地20 余名脾胃病知名专家对本共识意见( 草案) 进行了第三次投票，并进行了讨论和修改。2016 年7 月，在哈尔滨第28 届全国脾胃病学术会议上专家再次进行了讨论、修改和审定，并于2016 年9 月在北京召开了本共识的最后专家定稿会议，完成了本共识意见的制定 <BR></P> <P> </P>拓展指南：<strong>与<font color=red>脂肪肝</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e140a1c001a6e0c8" title="2017 亚太工作组指南：非酒精性脂肪肝" target=_blank>2017 亚太工作组指南：非酒精性脂肪肝</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=409d31c0011969f1" title="ESPGHAN共识声明：伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性（2015年）" target=_blank>ESPGHAN共识声明：伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性（2015年）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=841791c0011590c0" title="非酒精性脂肪肝肝活检评估共识" target=_blank>非酒精性脂肪肝肝活检评估共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7f1ae1c0011a8e9a" title="2015 JSGE循证临床实践指南：非酒精性脂肪肝病/非酒精性脂肪肝炎" target=_blank>2015 JSGE循证临床实践指南：非酒精性脂肪肝病/非酒精性脂肪肝炎</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=93b281c0011a0690" title="2015 ESPGHAN共识声明：伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性" target=_blank>2015 ESPGHAN共识声明：伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%84%82%E8%82%AA%E8%82%9D" target=_blank>有关脂肪肝更多指南</a></ul>, tagList=[TagDto(tagId=455, tagName=非酒精性脂肪性肝病), TagDto(tagId=37873, tagName=中医诊疗)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5627, appHits=369, showAppHits=0, pcHits=4069, showPcHits=1675, likes=145, shares=171, comments=9, approvalStatus=1, publishedTime=Wed Oct 11 23:12:54 CST 2017, publishedTimeString=2017-10-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 11 23:12:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Dec 30 10:13:07 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=非酒精性脂肪性肝病中医诊疗专家共识意见（2017）)])
非酒精性脂肪性肝病中医诊疗专家共识意见（2017）
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=254536, encodeId=bec32545362c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Oct 20 09:01:40 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254157, encodeId=35b925415e51, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Oct 19 00:56:32 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252996, encodeId=8daa2529968f, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Oct 15 06:35:52 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252170, encodeId=71452521e04f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Thu Oct 12 07:21:44 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252111, encodeId=83492521112d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Oct 12 06:35:40 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-20 1581f8c42cm

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=254536, encodeId=bec32545362c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Oct 20 09:01:40 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254157, encodeId=35b925415e51, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Oct 19 00:56:32 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252996, encodeId=8daa2529968f, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Oct 15 06:35:52 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252170, encodeId=71452521e04f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Thu Oct 12 07:21:44 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252111, encodeId=83492521112d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Oct 12 06:35:40 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-19 1581f8c42cm

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=254536, encodeId=bec32545362c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Oct 20 09:01:40 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254157, encodeId=35b925415e51, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Oct 19 00:56:32 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252996, encodeId=8daa2529968f, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Oct 15 06:35:52 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252170, encodeId=71452521e04f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Thu Oct 12 07:21:44 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252111, encodeId=83492521112d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Oct 12 06:35:40 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-15 Drhzm308

    谢谢.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=254536, encodeId=bec32545362c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Oct 20 09:01:40 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254157, encodeId=35b925415e51, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Oct 19 00:56:32 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252996, encodeId=8daa2529968f, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Oct 15 06:35:52 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252170, encodeId=71452521e04f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Thu Oct 12 07:21:44 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252111, encodeId=83492521112d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Oct 12 06:35:40 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-12 榄枷檬

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=254536, encodeId=bec32545362c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Oct 20 09:01:40 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254157, encodeId=35b925415e51, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Oct 19 00:56:32 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252996, encodeId=8daa2529968f, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Oct 15 06:35:52 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252170, encodeId=71452521e04f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Thu Oct 12 07:21:44 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252111, encodeId=83492521112d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Oct 12 06:35:40 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-12 1e1c07bdm01(暂无匿称)

    好

    0

相关指南

2016 NICE指南：非酒精性脂肪性肝病（NAFLD）的评估和管理（NG.49）

暂未更新 · 2016-07-06